INVESTMENT WATCH- SPE Capital Partners takes stake in Future Pharm. Industries: SPE Capital Partners made an equity investment in Egyptian pharma company Future Pharm. Industries (FPI) through its SPE AIF I fund, according to a company statement (pdf). The size of the investment was not disclosed. The agreement is a result of talks that have been ongoing for the past year. FPI positions itself as one of the fastest-growing manufacturers of generics in Egypt, according to the statement. SPE Capital’s SPE AIF I is PE fund that targets small and lower-mid cap companies valued at between USD 30 and USD 80 mn. SPE, previously known as Swicorp Capital, already has a stake in Egypt’s Orchidia.
More from Enterprise
Banque du Caire’s blockbuster IPO holds firm against EGX selloff
The IFC and the EBRD are in for USD 100…
Can AI promise Egypt’s lenders more borrowers and fewer bad loans?
Banks are cautious about letting AI judge a borrower. Local…
Egypt’s funds crossed EGP 500 bn in 3Q on retail money and a stalling core
Money market funds stalled while retail piled into equity, index,…
DPI closes Egypt-born fintech fund Nclude at USD 112 mn
The final close adds roughly USD 7 mn to a…